Science

Bristol-Myers Squibb Studying Impact of Cancer Survivorship

In the Know: Latest Topics in Science and Research
Multimedia with summary

Bristol-Myers Squibb is committed to studying the impact on survivorship throughout the continuum of cancer care with the goal improving communication between patients and their care teams about quality of survival in cancer.

Research on the survivorship concept shows us that this is a growing concern, but there is a lack of a standardized definition and appropriate measures to evaluate the quality of survivorship, resulting in a new need for and focus on care beyond diagnosis and treatment.

Apply to be an Amgen Scholar at Washington University in St. Louis

Blog

Washington University in St. Louis

PROGRAM DATES
May 30 - August 5, 2016

APPLICATION DEADLINE
February 1, 2016

Apply to be an Amgen Scholar

Apply to be an Amgen Scholar at Stanford

Blog

Stanford University

PROGRAM DATES
June 18 - August 20, 2016

APPLICATION DEADLINE
February 1, 2016

Aparna's Story: Redefining Possibilities for Patients with Rare Diseases

Article

Aparna had only been working as a clinical programmer on Bristol-Myers Squibb’s Global Biometrics Sciences team for six months when five-year-old Tayjus was diagnosed with Duchenne Muscular Dystrophy (DMD). Universal support from managers, co-workers, friends and family has helped her redefine what can be achieved by focusing on one day, and one goal, at a time.

Pages

Subscribe to Science